NCT04955834View on ClinicalTrials.gov

A Clinical Study of Insulin Degludec Injection in Subjects With Type 2 Diabetes

PHASE3RecruitingINTERVENTIONAL
Enrollment

344

Participants

Timeline

Start Date

July 27, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Type 2 Diabetes
Interventions
DRUG

Insulin degludec injection

long-acting insulin

DRUG

Tresiba®

long-acting insulin

Trial Locations (2)

400010

RECRUITING

The First Affiliated Hospital of Chongqing Medical University, Chongqing

410013

RECRUITING

The Second Xiangya Hospital of Central South University, Changsha

Sponsors
All Listed Sponsors
lead

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

INDUSTRY